Professor Matthew Kiernan
CEOMale0.0Global Dominance: 0.00%
Professor Matthew Kiernan is the CEO of Neuroscience Research Australia (NeuRA), who is instrumental in developing clinical pathways for the pTau217 test, aiming to improve the early diagnosis and treatment of Alzheimer's disease across Australia.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
NeuRA CEO Professor Matthew Kiernan said the centre would create clinical pathways to receive blood samples from doctors across Australia.
How the new TGA-approved P-tau217 test detects the disease decades before symptoms appearThe Sydney Morning Herald·
Australia· 2026-07-29
Australia· 2026-07-29
